BACKGROUND: Because of several side effects, the corticosteroid usage has been minimized in kidney transplantation. The increased acute rejection episodes associated with their withdrawal may counterbalance with induction treatment using polyclonal antilymphocyte globulin (ALG). The effects of ALG on blood cell phenotype have already been the subject of several reports. However, to date, no data are available concerning the comparison of blood phenotype when ALG is given with or without steroids and no gene profiling study has been performed. METHODS: We report here on a longitudinal blood cell analysis of a selected cohort of kidney recipients enrolled in a randomized study of steroid avoidance or withdrawal (during 6 months) during ALG induction. RESULTS: In the two groups, ALG quickly and massively depleted all the T cells and natural killer cells, but not B cells. Interestingly, the lymphopenia-driven homeostatic proliferation of CD4 and CD8T cells strongly differed with persistent low CD4 (including CD25CD4) T-cell counts. Effector memory CD8T cells reappeared rapidly. ALG induced apoptosis-associated molecules and increased myeloid cell genes. However, few genes were found differentially expressed with a low fold ratio between the two groups during and at distance of corticotherapy. CONCLUSION: Thus initial steroid avoidance or withdrawal associated with ALG induction has a weak influence on phenotype and transcriptional pattern of blood leukocytes. In contrast, ALG therapy induces an early and strong depletion of all T-cell subsets with contrasted long-lasting homeostatic regulation.
RCT Entities:
BACKGROUND: Because of several side effects, the corticosteroid usage has been minimized in kidney transplantation. The increased acute rejection episodes associated with their withdrawal may counterbalance with induction treatment using polyclonal antilymphocyte globulin (ALG). The effects of ALG on blood cell phenotype have already been the subject of several reports. However, to date, no data are available concerning the comparison of blood phenotype when ALG is given with or without steroids and no gene profiling study has been performed. METHODS: We report here on a longitudinal blood cell analysis of a selected cohort of kidney recipients enrolled in a randomized study of steroid avoidance or withdrawal (during 6 months) during ALG induction. RESULTS: In the two groups, ALG quickly and massively depleted all the T cells and natural killer cells, but not B cells. Interestingly, the lymphopenia-driven homeostatic proliferation of CD4 and CD8T cells strongly differed with persistent low CD4 (including CD25CD4) T-cell counts. Effector memory CD8T cells reappeared rapidly. ALG induced apoptosis-associated molecules and increased myeloid cell genes. However, few genes were found differentially expressed with a low fold ratio between the two groups during and at distance of corticotherapy. CONCLUSION: Thus initial steroid avoidance or withdrawal associated with ALG induction has a weak influence on phenotype and transcriptional pattern of blood leukocytes. In contrast, ALG therapy induces an early and strong depletion of all T-cell subsets with contrasted long-lasting homeostatic regulation.
Authors: M R L Marco; E M Dons; D J van der Windt; J K Bhama; L T Lu; A F Zahorchak; F G Lakkis; D K C Cooper; M B Ezzelarab; A W Thomson Journal: Transpl Immunol Date: 2013-10-09 Impact factor: 1.708
Authors: V D K D Sewgobind; L J W van der Laan; M M L Kho; R Kraaijeveld; S S Korevaar; W Mol; W Weimar; C C Baan Journal: Clin Exp Immunol Date: 2010-05-28 Impact factor: 4.330
Authors: Camila Macedo; John T Walters; Elizabeth A Orkis; Kumiko Isse; Beth D Elinoff; Sheila P Fedorek; John M McMichael; Geetha Chalasani; Parmjeet Randhawa; Anthony J Demetris; Adriana Zeevi; Henkie Tan; Ron Shapiro; Doug Landsittel; Fadi G Lakkis; Diana Metes Journal: Transplantation Date: 2012-04-27 Impact factor: 4.939
Authors: K Setoguchi; A D Schenk; D Ishii; Y Hattori; W M Baldwin; K Tanabe; R L Fairchild Journal: Am J Transplant Date: 2011-04-05 Impact factor: 8.086
Authors: S H C Havenith; E B M Remmerswaal; F J Bemelman; S L Yong; K A M I van Donselaar-van der Pant; R A W van Lier; I J M Ten Berge Journal: Clin Exp Immunol Date: 2012-09 Impact factor: 4.330
Authors: Yevgeniy A Grigoryev; Sunil M Kurian; Zafi Avnur; Dominic Borie; Jun Deng; Daniel Campbell; Joanna Sung; Tania Nikolcheva; Anthony Quinn; Howard Schulman; Stanford L Peng; Randolph Schaffer; Jonathan Fisher; Tony Mondala; Steven Head; Stuart M Flechner; Aaron B Kantor; Christopher Marsh; Daniel R Salomon Journal: PLoS One Date: 2010-10-14 Impact factor: 3.240
Authors: David S Segundo; Gema Fernández-Fresnedo; María Gago; Iñaki Beares; Marta González; Juan C Ruiz; Manuel Arias; Marcos López-Hoyos Journal: Kidney Int Suppl (2011) Date: 2011-08